How naltrexone works
Naltrexone occupies opioid receptors without switching them on. That one action has two different treatment uses: changing part of alcohol's reward response and blocking opioid effects after withdrawal.
Think of a receptor as a parking space
Opioids and some of the body’s own signalling chemicals normally bind to opioid receptors. Naltrexone has a strong attraction to those receptors, takes up the space, and blocks other substances from activating it.
That does not make naltrexone a safer way to use opioids or alcohol. The blockade can be overcome by sufficiently large opioid doses, which makes trying to override it dangerous. Alcohol can still impair judgement, coordination, breathing, and safety even when part of its reward signal changes.

One blockade, two treatment contexts
The practical meaning depends on what is being treated.
- With alcohol. Opioid-receptor blockade can reduce one part of alcohol’s reinforcing effect. Some people have less craving or fewer heavy-drinking days; others do not respond in the same way.
- With opioids. Usual opioid effects may be reduced or blocked after naltrexone is started safely. Naltrexone does not ease the withdrawal that must happen first.
- After treatment changes. Tolerance may be lower after a missed injection, near the end of a dosing interval, or after treatment stops. Returning to a previously used opioid amount can cause overdose.
- Alongside support. Craving, heavy drinking, relapse, retention, and quality of life are different outcomes. The medicine is one part of a broader treatment plan.
In everyday terms

Why alcohol can feel different
Alcohol affects several brain systems. Naltrexone blocks opioid-receptor signalling involved in part of the reward response, but it does not switch off alcohol’s other effects.
For some people, drinking becomes less compelling or heavy-drinking episodes become less frequent. That is a treatment possibility, not a guaranteed feeling. The evidence does not support a fixed timeline in which the brain simply ‘unlearns’ alcohol reward for everyone.

Why study results sound inconsistent
Different studies can all be accurate while measuring different things.
- The goal differs. Avoiding all alcohol, reducing heavy-drinking days, preventing opioid relapse, and staying in treatment are not the same outcome.
- The form differs. A daily tablet and a monthly injection create different adherence and appointment demands. The form differs
- The setting differs. Follow-up, counselling, housing, mental health, pain care, and overdose support can change what happens around the medicine.
Mechanism questions without the jargon
How long does oral blockade last?
The US oral label describes controlled heroin-challenge results over roughly 24 hours after 50 mg, with longer blockade after larger studied doses. Those experiments are not a personal timetable for opioid use or emergency pain treatment.
Does naltrexone remove cravings?
It may reduce craving or heavy-drinking outcomes for some people, but not everyone notices the same change. A follow-up plan should define what improvement would look like for that person.
Why must opioids be stopped first?
Naltrexone can rapidly displace opioid effects from receptors. In someone who is physically dependent, that can trigger severe precipitated withdrawal.
Is it safer than methadone or buprenorphine?
They are different medicines with different benefits, risks, and initiation barriers. Naltrexone has no opioid effect, but the required opioid-free interval can make it harder to start and may not suit every person.
See how the mechanism changes the treatment choice
Compare naltrexone with acamprosate and disulfiram, or read the more detailed guide to targeted naltrexone before discussing an approach with a clinician.
Compare alcohol-treatment medicinesExplore targeted naltrexone
Sources
Checked .
- Current US oral naltrexone prescribing information (DailyMed). Mechanism, blockade experiments, contraindications, and overdose warnings.
- Current US Vivitrol prescribing information (DailyMed). Extended-release formulation, indications, administration, and safety warnings.